-
1
-
-
19744376800
-
Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients
-
Miwa S, Watada H, Omura C, et al. Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients. Endocr J 52: 259–264, 2005.
-
(2005)
Endocr J
, vol.52
, pp. 259-264
-
-
Miwa, S.1
Watada, H.2
Omura, C.3
-
2
-
-
0042348740
-
HMG CoA reductase inhibitors and the skeletal: A comprehensive review
-
Bauer DC. HMG CoA reductase inhibitors and the skeletal: A comprehensive review. Osteoporos Int 14: 273–282, 2003.
-
(2003)
Osteoporos Int
, vol.14
, pp. 273-282
-
-
Bauer, D.C.1
-
3
-
-
23744495979
-
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: A meta-analysis
-
Hatzigeorgiou C, Jackson JL. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: A meta-analysis. Osteoporos Int 16: 990–998, 2005.
-
(2005)
Osteoporos Int
, vol.16
, pp. 990-998
-
-
Hatzigeorgiou, C.1
Jackson, J.L.2
-
4
-
-
0033521078
-
Stimulation of bone formation in vitro and in rodents by statins
-
Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946–1949, 1999.
-
(1999)
Science
, vol.286
, pp. 1946-1949
-
-
Mundy, G.1
Garrett, R.2
Harris, S.3
-
5
-
-
0034685669
-
Compactin and simvastatin, but not pravastatin, induce bone mor-phogenetic protein-2 in human osteosarcoma cells
-
Sugiyama M, Kodama T, Konishi K, Abe K, Asami S, Oikawa S. Compactin and simvastatin, but not pravastatin, induce bone mor-phogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 271: 688–692, 2000.
-
(2000)
Biochem Biophys Res Commun
, vol.271
, pp. 688-692
-
-
Sugiyama, M.1
Kodama, T.2
Konishi, K.3
Abe, K.4
Asami, S.5
Oikawa, S.6
-
6
-
-
0035929257
-
Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts
-
Ohnaka K, Shimoda S, Nawata H, et al. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun 287: 337–342, 2001.
-
(2001)
Biochem Biophys Res Commun
, vol.287
, pp. 337-342
-
-
Ohnaka, K.1
Shimoda, S.2
Nawata, H.3
-
7
-
-
0037214223
-
The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity
-
Staal A, Frith JC, French MH, et al. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res 18: 88–96, 2003.
-
(2003)
J Bone Miner Res
, vol.18
, pp. 88-96
-
-
Staal, A.1
Frith, J.C.2
French, M.H.3
-
8
-
-
0037002897
-
Statins decrease bone turnover in postmenopausal women: A cross-sectional study
-
Rejnmark L, Buus NH, Vestergaard P, Andreasen F, Larsen ML, Mosekilde L. Statins decrease bone turnover in postmenopausal women: A cross-sectional study. Eur J Clin Invest 32: 581–589, 2002.
-
(2002)
Eur J Clin Invest
, vol.32
, pp. 581-589
-
-
Rejnmark, L.1
Buus, N.H.2
Vestergaard, P.3
Andreasen, F.4
Larsen, M.L.5
Mosekilde, L.6
-
9
-
-
0142227255
-
Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia
-
Kajinami K, Takekoshi N, Matsui S, et al. Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 92: 1113–1116, 2003.
-
(2003)
Am J Cardiol
, vol.92
, pp. 1113-1116
-
-
Kajinami, K.1
Takekoshi, N.2
Matsui, S.3
-
10
-
-
0242408377
-
Atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces bone resorption in the elderly
-
Kuzuya M, Suzuki Y, Asai T, et al. Atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces bone resorption in the elderly. J Am Geriatr Soc 51: 1677–1678, 2003.
-
(2003)
J Am Geriatr Soc
, vol.51
, pp. 1677-1678
-
-
Kuzuya, M.1
Suzuki, Y.2
Asai, T.3
-
11
-
-
3042634621
-
Age-dependent effects of atorvastatin on biochemical bone turnover markers: A randomized controlled trial in postmenopausal women
-
Berthold HK, Unverdorben S, Zittermann A, et al. Age-dependent effects of atorvastatin on biochemical bone turnover markers: A randomized controlled trial in postmenopausal women. Osteoporos Int 15: 459–467, 2004.
-
(2004)
Osteoporos Int
, vol.15
, pp. 459-467
-
-
Berthold, H.K.1
Unverdorben, S.2
Zittermann, A.3
-
12
-
-
4344674934
-
The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes
-
Braatvedt GD, Bagg W, Gamble G, Davidson J, Reid IR. The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes. Bone 35: 766–770, 2004.
-
(2004)
Bone
, vol.35
, pp. 766-770
-
-
Braatvedt, G.D.1
Bagg, W.2
Gamble, G.3
Davidson, J.4
Reid, I.R.5
-
13
-
-
0034957690
-
The effect of fluvastatin on parameters of bone remodeling
-
Bjarnason NH, Riis BJ, Christiansen C. The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int 12: 380–384, 2001.
-
(2001)
Osteoporos Int
, vol.12
, pp. 380-384
-
-
Bjarnason, N.H.1
Riis, B.J.2
Christiansen, C.3
-
14
-
-
0035319125
-
Simvastatin/ Atorvastatin Study Group
-
Stein EA, Farnier M, Waldstreicher J, Mercuri M. Simvastatin/ Atorvastatin Study Group. Effects of statins on biomarkers of bone metabolism: A randomised trial. Nutr Metab Cardovasc Dis 11: 84–87, 2001.
-
(2001)
Effects of statins on biomarkers of bone metabolism: A randomised trial. Nutr Metab Cardovasc Dis
, vol.11
, pp. 84-87
-
-
Stein, E.A.1
Farnier, M.2
Waldstreicher, J.3
Mercuri, M.4
-
15
-
-
3242799093
-
Effects of simvastatin on bone turnover and BMD: A 1-year randomized controlled trial in postmenopausal osteopenic women
-
Rejnmark L, Buus NH, Vestergaard P, et al. Effects of simvastatin on bone turnover and BMD: A 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res 19: 737–744, 2004.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 737-744
-
-
Rejnmark, L.1
Buus, N.H.2
Vestergaard, P.3
-
16
-
-
25844456644
-
Short-term reduction in bone markers with high-dose simvastatin
-
Rosenson RS, Tangney CC, Langman CB, Parker TS, Levine DM, Gordon BR. Short-term reduction in bone markers with high-dose simvastatin. Osteoporos Int 16: 1272–1276, 2005.
-
(2005)
Osteoporos Int
, vol.16
, pp. 1272-1276
-
-
Rosenson, R.S.1
Tangney, C.C.2
Langman, C.B.3
Parker, T.S.4
Levine, D.M.5
Gordon, B.R.6
-
17
-
-
0035344642
-
Effects of 1-year treatment with fluvastatin or pravastatin on bone
-
Watanabe S, Fukumoto S, Takeuchi Y, Fujita H, Nakano T, Fujita T. Effects of 1-year treatment with fluvastatin or pravastatin on bone. Am J Med 110: 584–587, 2001.
-
(2001)
Am J Med
, vol.110
, pp. 584-587
-
-
Watanabe, S.1
Fukumoto, S.2
Takeuchi, Y.3
Fujita, H.4
Nakano, T.5
Fujita, T.6
-
18
-
-
33947602882
-
Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia
-
Majima T, Komatsu Y, Fukao A, Ninomiya K, Matsumura T, Nakao K. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia. Endocr J 54: 145–151, 2007.
-
(2007)
Endocr J
, vol.54
, pp. 145-151
-
-
Majima, T.1
Komatsu, Y.2
Fukao, A.3
Ninomiya, K.4
Matsumura, T.5
Nakao, K.6
-
19
-
-
0036231636
-
Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia
-
Saito Y, Yamada N, Teramoto T, et al. Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison. Arzneimittelforschung 52: 251–255, 2002.
-
(2002)
Dose-finding study using the double-blind, three-group parallel comparison. Arzneimittelforschung
, vol.52
, pp. 251-255
-
-
Saito, Y.1
Yamada, N.2
Teramoto, T.3
-
20
-
-
3042590478
-
Hip fracture risk in statin users-a population-based Danish case-control study
-
Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sorensen HT, Mosekilde L. Hip fracture risk in statin users-a population-based Danish case-control study. Osteoporos Int 15: 452–458, 2004.
-
(2004)
Osteoporos Int
, vol.15
, pp. 452-458
-
-
Rejnmark, L.1
Olsen, M.L.2
Johnsen, S.P.3
Vestergaard, P.4
Sorensen, H.T.5
Mosekilde, L.6
-
21
-
-
0034626389
-
Lack of positive correlation between statin use and bone mineral density in Japanese subjects with type 2 diabetes
-
Wada Y, Nakamura Y, Koshiyama H. Lack of positive correlation between statin use and bone mineral density in Japanese subjects with type 2 diabetes. Arch Intern Med 160: 2865–2870, 2000.
-
(2000)
Arch Intern Med
, vol.160
, pp. 2865-2870
-
-
Wada, Y.1
Nakamura, Y.2
Koshiyama, H.3
-
22
-
-
0036063969
-
Relation of statin use and bone loss: A prospective population-based cohort study in early postmenopausal women
-
Sirola J, Honkanen R, Kroger H, Jurvelin JS, Maenpaa P, Saarik-oski S. Relation of statin use and bone loss: A prospective population-based cohort study in early postmenopausal women. Osteoporos Int 13: 537–541, 2002.
-
(2002)
Osteoporos Int
, vol.13
, pp. 537-541
-
-
Sirola, J.1
Honkanen, R.2
Kroger, H.3
Jurvelin, J.S.4
Maenpaa, P.5
Saarik-oski, S.6
-
23
-
-
0037318567
-
Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation
-
Maeda T, Kawane T, Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology 144: 681–692, 2003.
-
(2003)
Endocrinology
, vol.144
, pp. 681-692
-
-
Maeda, T.1
Kawane, T.2
Horiuchi, N.3
-
24
-
-
0141988934
-
Pitavastatin efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor
-
Kajinami K, Takekoshi N, Saito Y. Pitavastatin efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Cardiovasc Drug Rev 21: 199–215, 2003.
-
(2003)
Cardiovasc Drug Rev
, vol.21
, pp. 199-215
-
-
Kajinami, K.1
Takekoshi, N.2
Saito, Y.3
-
25
-
-
1642341604
-
Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation
-
Oxlund H, Andreassen TT. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. Bone 34: 609–618, 2004.
-
(2004)
Bone
, vol.34
, pp. 609-618
-
-
Oxlund, H.1
Andreassen, T.T.2
-
26
-
-
0034765171
-
Changes in bone biochemical markers after high-dose cerivastatin treatment in a woman with osteogenesis imperfecta
-
Sugiyama T, Kawai S. Changes in bone biochemical markers after high-dose cerivastatin treatment in a woman with osteogenesis imperfecta. J Bone Miner Metab 19: 382–384, 2001.
-
(2001)
J Bone Miner Metab
, vol.19
, pp. 382-384
-
-
Sugiyama, T.1
Kawai, S.2
-
27
-
-
0344877301
-
Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: Results from a randomized placebo-controlled trial
-
Morii H, Ohashi Y, Taketani Y, et al. Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: Results from a randomized placebo-controlled trial. Osteoporos Int 14: 793–800, 2003.
-
(2003)
Osteoporos Int
, vol.14
, pp. 793-800
-
-
Morii, H.1
Ohashi, Y.2
Taketani, Y.3
-
28
-
-
0023690733
-
Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease
-
Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 297: 960–963, 1988.
-
(1988)
BMJ
, vol.297
, pp. 960-963
-
-
Lind, L.1
Jakobsson, S.2
Lithell, H.3
Wengle, B.4
Ljunghall, S.5
-
29
-
-
0031698795
-
Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EP1DOS prospective study
-
Garnero P, Dargent-Molina P, Hans D, et al. Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EP1DOS prospective study. Osteoporos Int 8: 563–569, 1998.
-
(1998)
Osteoporos Int
, vol.8
, pp. 563-569
-
-
Garnero, P.1
Dargent-Molina, P.2
Hans, D.3
-
30
-
-
18044393805
-
Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alen-dronate in postmenopausal Japanese women with osteoporosis
-
Iwamoto J, Takeda T, Sato Y, Uzawa M. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alen-dronate in postmenopausal Japanese women with osteoporosis. J Bone Miner Metab 23: 238–242, 2005.
-
(2005)
J Bone Miner Metab
, vol.23
, pp. 238-242
-
-
Iwamoto, J.1
Takeda, T.2
Sato, Y.3
Uzawa, M.4
-
31
-
-
0034921518
-
Hypercholesterolemia as a possible risk factor for osteopenia in type 2 diabetes mellitus
-
Koshiyama H, Wada Y, Nakamura Y. Hypercholesterolemia as a possible risk factor for osteopenia in type 2 diabetes mellitus. Arch Intern Med 161: 1678, 2001.
-
(2001)
Arch Intern Med
, vol.161
, pp. 1678
-
-
Koshiyama, H.1
Wada, Y.2
Nakamura, Y.3
-
32
-
-
23744489123
-
Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients
-
Majima T, Komatsu Y, Yamada T, et al. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 16: 907–913, 2005.
-
(2005)
Osteoporos Int
, vol.16
, pp. 907-913
-
-
Majima, T.1
Komatsu, Y.2
Yamada, T.3
|